Health Canada. Population and Public Health Branch. West Nile virus. Surveillance data. April 9, 2003. Available: www.hc-sc.gc.ca/pphb-dgspsp/wnv-vwn/index.html (accessed May 10, 2004).
2.
Gea-BanaclocheJJohnsonRTBagicAWest Nile virus: pathogenesis and therapeutic options. Ann Intern Med2004;140:545–53.
3.
SolomonTOoiMHBeasleyDWCMallewaM. West Nile encephalitis. BMJ2003;326:865–9.
4.
Infectious Diseases and Immunization Committee. Canadian Paediatric Society. PID Note: West Nile virus. Paediatrics & Child Health2003;8(5):267–70.
5.
FradinMS. Mosquitoes and mosquito repellents: a clinician's guide. Ann Intern Med1998;128:931–40. Available: www.annals.org/cgi/content/full/128/11/931 (accessed May 26, 2004).
6.
BrownMHebertAA. Insect repellents: an overview. J Am Acad Dermatol1997;36:243–9.
7.
Personal insect repellents containing DEET (N,N-diethyl-m-toluamide and related compounds) [Re-evaluation Decision Document RRD2002-01]. Ottawa: Pest Management Regulatory Agency, Health Canada; 2002 Apr 15. Available: www.hc-sc.gc.ca/pmra-arla/english/pdf/rrd/rrd2002-01-e.pdf (accessed May 26, 2004).
KorenGMatsuiDBaileyB. DEET-based insect repellents: safety implications for children and pregnant and lactating women. CMAJ2003;169(3):209–12.
14.
National Pesticide Telecommunications Network. DEET [General Fact Sheet], U.S. Environmental Protection Agency, March 2000.
15.
GoodyerLBehrensRH. Short report: the safety and toxicity of insect repellents. Am J Trop Med Hyg1998;59(2):323–4.
16.
BellJWVeltriJCPageBC. Human exposures to N,N-diethyl-m-toluamide insect repellents reported to the American Association of Poison Control Centers 1993–1997. Int J Toxicol2002;21:341–52.